Table S1.
TCGA Patient clinical and pathological characteristics (N=394). Univariate analysis with Cox proportional Hazard ratio was used to assess differences between both groups
| Recurred (N=49) | Not recurred (N=345) | p-value | ||
|---|---|---|---|---|
| Preoperative characteristics | Age (mean) | 63 | 62 | 0.618 |
| BMI (mean) | 33.2 | 33.1 | 0.742 | |
| Grade | 0.001 | |||
| 1 | 4 | 93 | ||
| 2 | 14 | 99 | ||
| 3 | 31 | 153 | ||
| Level of risk | 0.007 | |||
| Low | 17 | 189 | ||
| High | 32 | 156 | ||
| Postoperative characteristics | Myometrial invasion | 0.515 | ||
| <50% | 22 | 238 | ||
| >50% | 3 | 14 | ||
| 2009 FIGO Stage | <0.001 | |||
| I | 25 | 252 | ||
| II | 2 | 31 | ||
| III | 16 | 55 | ||
| IV | 6 | 7 | ||
| Lymph nodes (positive) | 14 (33%) | 27 (10%) | <0.001 | |
| Peritoneal Cytology (positive) | 8 (18%) | 20 (8%) | 0.024 |
Abbreviations: BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; TCGA, the Cancer Genome Atlas.